In Vivo Synthetic Anticancer Approach by Resourcing Mouse Blood Albumin as a Biocompatible Artificial Metalloenzyme.

MLA

Imai, Kyosuke, et al. “In Vivo Synthetic Anticancer Approach by Resourcing Mouse Blood Albumin as a Biocompatible Artificial Metalloenzyme.” Angewandte Chemie (International Ed. in English), vol. 63, no. 43, Oct. 2024, p. e202411225. EBSCOhost, https://doi.org/10.1002/anie.202411225.

APA

Imai, K., Muguruma, K., Nakamura, A., Kusakari, Y., Chang, T.-C., Pradipta, A. R., & Tanaka, K. (2024). In Vivo Synthetic Anticancer Approach by Resourcing Mouse Blood Albumin as a Biocompatible Artificial Metalloenzyme. Angewandte Chemie (International Ed. in English), 63(43), e202411225. https://doi.org/10.1002/anie.202411225

Chicago

Imai, Kyosuke, Kyohei Muguruma, Akiko Nakamura, Yuriko Kusakari, Tsung-Che Chang, Ambara R Pradipta, and Katsunori Tanaka. 2024. “In Vivo Synthetic Anticancer Approach by Resourcing Mouse Blood Albumin as a Biocompatible Artificial Metalloenzyme.” Angewandte Chemie (International Ed. in English) 63 (43): e202411225. doi:10.1002/anie.202411225.